Showing 273–288 of 414 resultsSorted by popularity
Methylstenbolone is a potent C17-alpha-alkylated androgen with a 9-12 hour half-life that drives rapid myofibrillar protein transcription and positive nitrogen balance. Its unique structure provides strong anabolic signaling without aromatization.
Dual GLP-1/GIP receptor agonist for weight management and metabolic research. Study incretin signaling and glucose regulation.
Ipamorelin is a third-generation selective ghrelin receptor agonist pentapeptide that triggers consistent growth hormone release without activating ACTH, prolactin, or cortisol pathways. Its 2-hour half-life produces a clean physiological GH pulse ideal for recovery and body composition research.
MK-2866 (Ostarine) is a non-steroidal SARM that selectively agonizes androgen receptors in muscle and bone tissue with a Ki of 3.8 nM. Its 24-hour half-life provides steady receptor occupancy for investigating lean tissue preservation and muscle wasting prevention.
RAD140 is a potent non-steroidal SARM with a 60-hour half-life that selectively agonizes skeletal muscle androgen receptors with minimal prostate or sebaceous gland activity. It drives myofibrillar protein synthesis and exhibits neuroprotective properties.
Anadrol (Oxymetholone) Injectable is a potent DHT derivative featuring a 2-hydroxymethylene group that enhances anabolic potency through non-genomic pathways and erythropoietin stimulation. The injectable delivery bypasses first-pass hepatic metabolism.
T4 (Levothyroxine) is a synthetic thyroid pro-hormone that requires peripheral deiodinase conversion to active T3 before exerting genomic effects. Its long half-life provides a stable, sustained thyroid hormone reservoir for metabolic and endocrine research.
Mild DHT-derived androgen for lean tissue research with low androgenic activity. Study nitrogen retention.
Cabergoline (Dostinex) is a potent dopamine D2 receptor agonist with a 65-hour half-life that selectively suppresses pituitary prolactin secretion by reducing intracellular cAMP. A key research tool for investigating prolactin modulation and HPTA optimization.
Winstrol (Stanozolol) Injectable Suspension is a pyrazole-modified DHT derivative that binds microsomal androgen receptors and inhibits SHBG synthesis, increasing free androgen bioavailability. The injectable delivery provides a 24-hour half-life with superior bioavailability.
DHT-derived androgen for SHBG modulation and lean mass research. Study vascularity and fat loss pathways.
Trenbolone Base is an unesterified 19-nor injectable androgen that provides immediate receptor saturation without the rate-limiting step of ester cleavage. Its trienic bond structure precludes aromatization while delivering pure, potent androgenic signaling.
End of content
End of content
No products in the cart.
